First Wave BioPharma News

First Wave BioPharma Analyst Ratings

BenzingaMar 25 06:42 ET

First Wave BioPharma Analyst Ratings

BenzingaMar 15 09:47 ET

Roth MKM Maintains Buy on First Wave BioPharma, Adjusts Price Target To $40

BenzingaJan 3 13:16 ET

Buy Rating Affirmed for First Wave BioPharma Amid Strategic Focus on Celiac Treatment

TipRanksJan 2 16:55 ET

Roth MKM Reiterates Buy on First Wave BioPharma, Maintains $11 Price Target

BenzingaSep 19, 2023 09:23 ET

First Wave BioPharma Analyst Ratings

BenzingaSep 19, 2023 09:22 ET

First Wave BioPharma Analyst Ratings

BenzingaJul 14, 2023 06:15 ET

HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $10 Price Target

BenzingaJun 29, 2023 06:14 ET

What 4 Analyst Ratings Have To Say About First Wave BioPharma

BenzingaJun 13, 2023 12:00 ET

HC Wainwright Adjusts First Wave BioPharma Price Target to $10 From $14, Maintains Buy Rating

MT NewswiresMay 15, 2023 07:41 ET

HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $14 Price Target

BenzingaApr 26, 2023 06:15 ET

HC Wainwright & Co. Maintains Buy on First Wave BioPharma, Lowers Price Target to $14

BenzingaApr 5, 2023 06:34 ET

HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $18 Price Target

BenzingaMar 9, 2023 08:59 ET

First Wave BioPharma Analyst Ratings

Benzinga Analyst RatingsFeb 3, 2023 06:13 ET

HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $18 Price Target

Benzinga Real-time NewsFeb 3, 2023 06:13 ET

First Wave BioPharma Analyst Ratings

Benzinga Analyst RatingsJan 31, 2023 11:42 ET

HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $18 Price Target

Benzinga Real-time NewsJan 31, 2023 11:42 ET

First Wave BioPharma Analyst Ratings

Benzinga Analyst RatingsJan 26, 2023 13:26 ET

First Wave BioPharma Analyst Ratings

Benzinga Analyst RatingsDec 2, 2022 05:08 ET

HC Wainwright & Co. Maintains Buy on First Wave BioPharma, Lowers Price Target to $4

Benzinga Real-time NewsDec 2, 2022 05:08 ET